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Abstract
Background: Coagulase-negative staphylococci, mainly Staphylococcus epidermidis, are the most frequent cause of late-
onset sepsis (LOS) in the neonatal intensive care unit (NICU) setting. However, recent reports indicate that methicillin-
resistant, vancomycin-heteroresistant Staphylococcus capitis could emerge as a significant pathogen in the NICU. We
investigated the prevalence, clonality and vancomycin susceptibility of S. capitis isolated from the blood of NICU infants and
compared these data to adult patients.
Methodology/Principal Findings: We conducted a retrospective laboratory-based survey of positive blood cultures in NICU
infants $3 days of age (n=527) and in adult ICU patients $18 years of age (n=1473) who were hospitalized from 2004 to
2009 in two hospital centers in Lyon, France. S. capitis was the most frequent pathogen in NICU infants, ahead of S.
epidermidis (39.1% vs. 23.5% of positive blood cultures, respectively). Conversely, S. capitis was rarely found in adult ICU
patients (1.0%) compared to S. epidermidis (15.3%). S. capitis bloodstream isolates were more frequently resistant to
methicillin when collected from NICU infants than from adult patients (95.6% vs. 53.3%, respectively). Furthermore, we
collected and characterized 53 S. capitis bloodstream isolates from NICU infants and adult patients from six distant cities. All
methicillin-resistant S. capitis isolates from NICU infants were clonally related as determined by pulsed-field gel
electrophoresis. These isolates harbored a type V-related staphylococcal chromosomal cassette mec element, and constantly
showed either vancomycin resistance (37.5%) or heteroresistance (62.5%). Conversely, the isolates that were collected
outside of the NICU were genetically diverse and displayed much lower rates of vancomycin resistance and heteroresistance
(7.7% and 23.1%, respectively).
Conclusions/Significance: A clonal population of methicillin-resistant S. capitis strains has spread into several French NICUs.
These isolates exhibit reduced susceptibility to vancomycin, which is the most widely used antimicrobial agent in the NICU
setting.
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Introduction
Constant improvements in neonatal intensive care have led to
better survival rates for very-low-birth-weight infants (VLBW,
,1500 g), but the high incidence of nosocomial, late-onset sepsis
(LOS, occurring after 3 days of age) is still a leading cause of
morbidity and mortality [1,2]. Coagulase-negative staphylococci
(CoNS) are the most frequently encountered pathogens in
bloodstream infections in neonatal intensive care units (NICUs)
[3,4]. Several risk factors for such infections have been identified,
including low gestational age, low birth weight [5], parenteral
nutrition with intravenous lipids, and the presence of a central
venous catheter [6,7]. Although CoNS bloodstream infections are
significantly less severe than those caused by other pathogens [4],
they lead to prolonged hospitalization and increased antibiotic
use [4,8].
Staphylococcus epidermidis has been shown to be the predominant
species in CoNS bacteremia in both adult and pediatric patients
[9–12]; in the NICU setting, it represents 70% of CoNS isolates
[12–15]. Among non-epidermidis CoNS, Staphylococcus capitis is
rarely, if ever, isolated from bacteremic adult patients [16].
Although this species has been occasionally reported in infective
endocarditis cases [17,18], it is most often considered to be a blood
culture contaminant [16]. However, in the NICU setting, recent
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emerge as a significant pathogen, causing LOS in VLBW infants
[14,19–22]. The high prevalence of methicillin-resistant CoNS in
NICUs usually leads to frequent vancomycin use. Concerns have
been raised about the spread of vancomycin-heteroresistant S.
capitis strains in NICUs and their involvement in persistent
bacteremia despite prolonged vancomycin therapy [19,20,23].
The unusually high prevalence of methicillin-resistant S. capitis
bloodstream infections in the NICUs of the University Hospital of
Lyon, France, prompted this study. The objectives were: (1) to
describe the species distribution of bloodstream CoNS isolates in
these NICUs; (2) to investigate the clonality of S. capitis that causes
LOS in the NICUs of Lyon, and compare it to S. capitis strains
found in adult patients and in other French NICUs; and (3) to
investigate vancomycin resistance and heteroresistance in these
strains.
Methods
Retrospective prevalence study
We conducted a retrospective laboratory-based survey of blood
cultures at two NICUs located in two different hospital centers
within the University Hospital of Lyon, France. Both NICUs
provide third-level neonatal care, with approximately 70%
(Northern Hospital Group) and 55% (Eastern Hospital Group)
of infants having VLBW. The inclusion period was from January
1, 2004 to December 31, 2009. The microbiological records of
blood cultures drawn from NICU infants after the third day of life
(to exclude early-onset sepsis) were obtained from the computer-
ized databases of the clinical microbiology laboratories of each
hospital. For comparison purposes, the blood culture results of
patients over 18 years of age who were hospitalized in the ICUs of
these hospitals during the study period were also reviewed. The
first positive blood culture result from each patient was considered
for analysis. We also determined the number of patients who had
different blood cultures positive with different pathogens. Both
participating microbiology laboratories performed species-level
identification of the bacterial isolates and antimicrobial suscepti-
bility testing (AST) with the automated BD Phoenix system
(Becton Dickinson, Sparks, MD). The AST results were interpret-
ed according to the recommendations of the French Society for
Microbiology [24].
Because the study was laboratory-based and no clinical data
were obtained, CoNS-positive blood cultures were interpreted to
be probable or possible CoNS bacteremia based on the number of
positive blood cultures and the patient setting (i.e., NICU infants
or adult ICU patients). In both NICU infants and adult ICU
patients, probable CoNS bacteremia was defined as $2 blood
culture sets positive with the same CoNS species within a 3-day
period [25]. CoNS-positive blood cultures in adult ICU patients
that did not match these criteria were excluded (n=585).
However, because repeated blood cultures are not frequently
performed in NICU infants compared to adult patients, single
CoNS-positive blood cultures in NICU infants were interpreted as
possible CoNS bacteremia and included for analysis. Seventeen
CoNS-positive blood cultures were excluded because they were
explicitly recorded as false positives in the microbiological record,
and thus not identified at the species level. Finally, we excluded
blood cultures that were positive with organisms considered to be
contaminants other than CoNS, including Bacillus spp. (n=4
NICU infants and 10 ICU patients) and Micrococcus spp. (n=1
NICU infant and 11 ICU patients).
The resistance patterns of S. capitis to penicillin, methicillin,
gentamicin, erythromycin, clindamycin, pristinamycin, rifampin,
fusidic acid and fluoroquinolones were recorded and compared
between NICU and adult ICU isolates. Two records were
excluded because AST results were incomplete and the corre-
sponding isolates could not be recovered from the strain collection
of the microbiology laboratory. The results regarding vancomycin
susceptibility were excluded from the analysis because the #4 mg/
L clinical breakpoint used during the 2004–2009 inclusion period
differed from the #2 mg/L clinical breakpoint recommended
since 2010 by the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) [26]. Because the study
consisted of a retrospective review of routine microbiological data
that were analyzed anonymously, approval by the ethics
committee and informed consent were not required.
S. capitis isolates
To investigate the population structure of S. capitis at the
regional level, S. capitis isolates were collected retrospectively
among routinely stored clinical strains from participating centers
in distant cities spanning the French territory, namely Caen,
Limoges, Lyon, Saint-Etienne, Troyes and Versailles. In each
laboratory, all bloodstream isolates with the exception of isolates
interpreted as contaminants were stored regardless of their
resistance profile, according to the French guidelines on bacterial
strain storage [27]. S. capitis bloodstream isolates from NICU
infants and adult/older pediatric patients regardless of their
methicillin resistance status were included. The inclusion period
was from January 2006 to April 2009 for the isolates collected
from the Northern Hospital Group of Lyon, and from January
2008 to April 2009 for the isolates collected from the other
participating centers because of the shorter duration of routine
storage of clinical strains in these laboratories. Because the strain
collection at Lyon consisted of a large number of S. capitis NICU
isolates (n=125), selection was restricted to 25 isolates using a
random sampling algorithm without replacement by means of the
XLStat software version 7.5.2 (Addinsoft SARL, Paris, France).
Additionally, an S. capitis strain that was involved in a previously
reported S. capitis outbreak at the NICU of Nantes from 2000 to
2003 was kindly provided by J. Caillon and also included in the
study [22]. A total of 53 isolates were investigated, including 40
isolates from NICU infants (Lyon, n=25; Limoges, n=7; Saint-
Etienne, n=3; Caen, n=2; Troyes, n=2; and Nantes, n=1) and
13 isolates from adult/older pediatrics patients (Lyon, n=12; and
Versailles, n=1). Species-level identification of all S. capitis isolates
included in this study was confirmed by amplification and
sequence analysis of the tuf gene as previously described [28].
Pulsed-field gel electrophoresis
All S. capitis isolates (n=53) were characterized by PFGE as
previously described [29]. Genomic DNA was digested with SmaI
restriction endonuclease, which discriminates well between
staphylococci, including S. capitis [30]. After staining with ethidium
bromide, electrophoresis gels were photographed and analyzed
with GelCompar software version 4.1 (Applied Math NV, Saint-
Martens-Latem, Belgium) using the unweighted pair group
method with arithmetic mean (UPGMA). The Dice correlation
coefficient was used to determine the similarity percentage
between DNA restriction patterns, which were assigned to
pulsotypes using .80% similarity with a band position tolerance
of 1% as previously described [31]. The genetic diversity of the
isolates from NICU infants was compared with the isolates from
adult/older pediatric patients using Simpson’s index of diversity
(SID), which is defined as the percentage probability that two
isolates chosen at random are unrelated [32].
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cassette mec typing
The susceptibility of the 53 selected isolates to oxacillin and
cefoxitin was determined by the standard agar diffusion technique
as recommended by the French Society for Microbiology [24].
SCCmec typing was performed on a subset of 23 methicillin-
resistant isolates representative of each pulsotype and geographic
origin. Multiplex PCRs were performed to determine the allelic
variants of both the chromosomal recombinase ccr gene complex
cassette and the mec locus according to the method established by
Kondo et al. [33]. Each combination of ccr and mec alleles was
related to an SCCmec type when applicable, following the
recommendations of the International Working Group on the
Classification of Staphylococcal Cassette Chromosome Elements
(IWG-SCC) [34].
Vancomycin resistance and heteroresistance testing
Vancomycin minimum inhibitory concentrations (MICs) were
determined using the E-Test method (AB Biodisk, Solna, Sweden)
with a McFarland density 0.5 inoculum on Mueller-Hinton agar
as recommended by the manufacturer. The E-Test method was
preferred to the CLSI broth microdilution reference method
because of its better performance at detecting staphylococci with
reduced vancomycin susceptibility [35,36]. Strains exhibiting a
vancomycin MIC.2 mg/L were considered to be resistant
according to EUCAST breakpoints [26]. Strains with a vanco-
mycin MIC#2 mg/L were tested for vancomycin heteroresistance
using the brain heart infusion (BHI) screen agar method as
previously described [37]. Briefly, an overnight blood agar plate
culture was suspended in 0.9% saline and adjusted to McFarland
0.5 turbidity. Four 10-mL droplets of the suspension were dropped
using a pipette onto a BHI agar plate (Difco, Becton Dickinson)
containing 16 g/L pancreatic digest of casein (Bacto, Becton
Dickinson) and 4 mg/mL vancomycin. Plates were incubated at
35uC and the colonies in each droplet were counted after 48 h. A
strain was considered to be heteroresistant to vancomycin if $1
droplet had $2 colonies. The vancomycin-susceptible S. aureus
strain ATCC 29213 was used as a negative control [37]. The
vancomycin-heteroresistant S. aureus strain Mu3 and the vanco-
mycin-resistant S. aureus strain Mu50 were used as positive controls
[38]. The results from each experiment were recorded only when
positive and negative controls were confirmed.
Statistical analysis
The differences in the prevalence of each bacterial species in the
positive blood cultures between patient groups and in the
antimicrobial resistance rates were analyzed using a two-tailed
Fisher’s exact test. P values were corrected for multiple testing
using the Holm-Bonferroni method where appropriate. The
differences in vancomycin MICs were analyzed using a non-
parametric two-tailed Mann-Whitney U-test. P values of #0.05
were considered to be statistically significant. All statistical tests
were performed using the XLStat software version 7.5.2.
Results
Methicillin-resistant S. capitis is the leading cause of LOS
in NICU infants
In total, 2,628 patients with positive blood cultures were
identified from the laboratory databases, and 2,000 cases were
included in the final analysis (Fig. 1). Blood cultures were more
likely to grow CoNS when drawn from NICU infants than from
adult ICU patients (P,0.001, two-tailed Fisher’s exact test with
Holm-Bonferroni correction; Table 1). S. capitis was the most
prevalent pathogen that caused bloodstream infections in NICU
infants (39.1%) but accounted for only 1.0% of positive blood
cultures from adult ICU patients (P,0.001). Overall, 54 out of 206
(26.2%) S. capitis-positive blood cultures from NICU infants
fulfilled the definition for probable CoNS sepsis ($2 blood culture
sets were positive with the same species within a 3-day period), and
152 (73.8%) blood cultures were thus considered to be possible S.
capitis sepsis. These proportions did not differ significantly from the
non-capitis CoNS-positive blood cultures (probable sepsis, n=41/
210, 19.5%; possible sepsis, n=169/210, 80.5%; P=0.13). There
was no significant evolution of S. capitis prevalence from 2004 to
2009 in either group of patients (data not shown).
The overall proportion of patients who had $2 blood cultures
positive with $2 different pathogens was significantly lower in
NICU infants than adult ICU patients (n=177/527, 33.6%, vs.
n=960/1473, 65.2%, respectively; P,0.001). Among patients
whose first positive blood culture grew S. capitis, NICU infants
were significantly less likely than adult ICU patients to have
subsequent blood cultures positive with another pathogen (n=49/
206, 23.8%, vs. n=8/15, 53.3%, respectively; P=0.03). Finally,
among patients whose first positive blood culture grew a pathogen
other than S. capitis, NICU infants were significantly more likely
than adult ICU patients to have subsequent blood cultures positive
with S. capitis (n=42/321, 13.1%, vs. n=16/1458, 1.1%,
respectively; P,0.001).
The antimicrobial resistance patterns of S. capitis bloodstream
isolates from NICU infants (n=204) and adult ICU patients
(n=15) were compared. The isolates exhibited specific antimicro-
bial susceptibility patterns depending on the patient setting
(Table 2). NICU isolates were more frequently resistant to beta-
lactams and gentamicin (P,0.001) than adult ICU isolates and
more frequently susceptible to erythromycin and fluoroquinolones
(P,0.05). Among the NICU isolates, the methicillin-resistant
isolates were more frequently resistant to gentamicin (P,0.001),
and more frequently susceptible to fusidic acid than were
methicillin-susceptible isolates (P,0.05; Table 3).
S. capitis isolates from distant NICUs are clonal and
harbor a type V-related SCCmec element
Of 53 selected isolates, 49 (92.5%) were resistant to methicillin,
including 39 NICU isolates (97.5%) and 10 non-NICU isolates
(76.9%). PFGE identified 13 different pulsotypes, designated as
NRCS-A to -M (Fig. 2). Except for a single methicillin-susceptible
isolate, all NICU isolates that were collected from 7 different
NICUs in 6 different cities belonged to the same pulsotype
(NRCS-A). In contrast, the 14 remaining isolates, including 1
methicillin-susceptible NICU isolate and 13 isolates from adult or
older pediatric patients, belonged to 13 different pulsotypes
(NRCS-A to -M). The only NRCS-A isolate that was not from a
NICU infant was collected from a 4-year-old patient who was
hospitalized in the pediatric ICU of Lyon. Simpson’s index of
diversity was 4.9% (95% CI, 0.0–14.3%) for the NICU isolates
and 91.1% (95% CI, 88.0–94.2%) for the adult/older pediatric
isolates.
SCCmec typing was applied to a subset of 23 methicillin-resistant
S. capitis isolates representative of each pulsotype and geographic
origin, and all NRCS-A isolates were found to share the mec
complex C and ccr C genes, whose combination matches the
features of SCCmec type V (Fig. 2) [34]. The same mec complex/ccr
gene combination was only found in one pulsotype NRCS-G
isolate from an adult patient from Versailles. The 7 remaining
methicillin-resistant isolates from adult patients belonged to
pulsotypes NRCS-D, -E, and -H to -L and were found to harbor
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mec complex C/ccr A2B2C (a combination that has not yet been
assigned to an SCCmec type to our knowledge).
NRCS-A isolates have reduced vancomycin susceptibility
The mean vancomycin MIC of NRCS-A isolates was
significantly higher (2.8 mg/L, range 1.5–12 mg/L) than the
NRCS-B to -M isolates (1.7 mg/L, range 1–4 mg/L; P,0.01,
two-tailed Mann-Whitney U-test) (Fig. 3). Regarding vancomycin
susceptibility, as interpreted using the EUCAST 2010 recommen-
dations [39], the proportion of vancomycin-resistant isolates was
4.9-fold higher in pulsotype NRCS-A than in the other pulsotypes
(37.5% vs. 7.7%, respectively; P=0.08, Fisher’s exact test).
Moreover, the proportion of vancomycin-heteroresistant isolates
was 2.7-fold higher in NRCS-A than in the other pulsotypes
(62.5% vs. 23.1%, respectively; P,0.05). All NRCS-A isolates with
Figure 1. Flow diagram of case selection. (N)ICU, (neonatal) intensive care unit; CoNS, coagulase-negative staphylococci; BC, blood culture.
aIn
NICU infants, a single CoNS-positive blood culture was interpreted as possible bacteremia and included in the analysis. The CoNS-positive results that
were excluded were explicitly recorded as a contaminant in the microbiology record.
bIn adult patients, a single CoNS-positive blood culture was
interpreted as a contaminant and excluded from the analysis.
cRecords were excluded when antimicrobial susceptibility results were not available.
doi:10.1371/journal.pone.0031548.g001
Table 1. A species distribution comparison of Staphylococcus spp. isolates from the positive blood cultures of patients in neonatal
intensive care units (NICUs) and adult ICUs, 2004–2009.
No. (%) of blood cultures (one per patient)
Blood culture result NICU infants Adult ICU patients P value
a Odds ratio (95% CI)
Total 527 1473
S. aureus 65 (12.3) 166 (11.3) 0.525 1.11 (0.82–1.50)
Coagulase-negative staphylococci 416 (78.9) 331 (22.5) ,0.001 12.9 (10.1–16.5)
S. epidermidis 124 (23.5) 226 (15.3) ,0.001 1.70 (1.33–2.17)
S. capitis 206 (39.1) 15 (1.0) ,0.001 62.4 (36.4–106.8)
Other CoNS species 86 (16.3) 90 (6.1) ,0.001 3.00 (2.19–4.10)
aThe differences between the groups were tested for statistical significance using a two-tailed Fisher’s exact test. P values were corrected for multiple testing using the
Holm-Bonferroni method.
doi:10.1371/journal.pone.0031548.t001
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Finally, the proportion of isolates exhibiting either vancomycin
resistance or heteroresistance was significantly higher in pulsotype
NRCS-A than in the other pulsotypes (100.0% vs. 30.8%,
respectively; P,0.001).
Discussion
Several major findings emerged from this retrospective study of
2,000 positive blood cultures from NICU infants and adult ICU
patients from 2004 to 2009 and from the molecular characteriza-
tion of a panel of S. capitis clinical isolates. First, methicillin-
resistant S. capitis was the most prevalent pathogen that caused
LOS in the NICUs of Lyon, France, whereas this species was
rarely isolated from the blood of adult ICU patients. Second, all
methicillin-resistant S. capitis bloodstream isolates collected from
several NICUs spanning the French territory belonged to the same
pulsotype, which was designated as pulsotype NRCS-A, whereas
the methicillin-susceptible isolates and the isolates from adult and
older pediatric patients exhibited high genetic diversity. Third,
pulsotype NRCS-A isolates constantly showed either vancomycin
resistance (37.5%) or heteroresistance (62.5%), whereas these rates
were 4.9- and 2.7-fold, respectively, lower in the isolates collected
outside of the NICU. Collectively, these findings indicate that a
clonal population of methicillin-resistant S. capitis exhibiting
reduced susceptibility to vancomycin has spread into several
NICUs in France.
S. capitis has been sporadically incriminated in NICU outbreaks
[22], but the prevalence of this pathogen as a cause of LOS in
French NICUs had not been investigated prior to this study.
Several surveillance programs, such as RAISIN and NEOCAT
[40,41], have focused on healthcare-associated bloodstream
infections in French ICUs and NICUs. However, S. capitis
prevalence could not be inferred from the results of these studies
because CoNS prevalence was not reported at the species level.
Table 2. A retrospective comparison of the antimicrobial resistance profiles of Staphylococcus capitis bloodstream isolates from
patients in neonatal intensive care units (NICUs) and adult ICUs, 2004–2009.
No. (%) of resistant isolates
Antimicrobial agent
NICU isolates
(n=204)
Adult ICU isolates
(n=15) P value
a Odds ratio (95% CI)
Penicillin 202 (99.0) 10 (66.7) ,0.001 50.5 (8.70–293.1)
Methicillin 195 (95.6) 8 (53.3) ,0.001 19.0 (5.63–63.9)
Gentamicin 194 (95.1) 3 (20.0) ,0.001 77.6 (18.8–319.7)
Erythromycin 29 (14.2) 7 (46.7) 0.022 0.19 (0.06–0.56)
Clindamycin 21 (10.3) 4 (26.7) 0.227 0.32 (0.09–1.08)
Pristinamycin 13 (6.4) 1 (6.7) 1.000 0.95 (0.12–7.82)
Rifampin 91 (44.6) 3 (20.0) 0.205 3.22 (0.88–11.8)
Fusidic acid 11 (5.4) 4 (26.7) 0.050 0.16 (0.04–0.57)
Fluoroquinolones 10 (4.9) 7 (46.7) ,0.001 0.06 (0.02–0.20)
aThe differences between the groups were tested for statistical significance using a two-tailed Fisher’s exact test. P values were corrected for multiple testing using the
Holm-Bonferroni method.
doi:10.1371/journal.pone.0031548.t002
Table 3. A retrospective comparison of the antimicrobial resistance profiles of methicillin-resistant and methicillin-susceptible
Staphylococcus capitis bloodstream isolates from patients in neonatal intensive care units, 2004–2009.
No. (%) of resistant isolates
Antimicrobial agent
Methicillin-resistant
isolates (n=195)
Methicillin-susceptible
isolates (n=9) P value
a Odds ratio (95% CI)
Penicillin 195 (100.0) 7 (77.8) ,0.001 NC
b
Gentamicin 192 (98.5) 2 (22.2) ,0.001 224.0 (32.1–1561.3)
Erythromycin 27 (13.8) 2 (22.2) 1.000 0.56 (0.11–2.85)
Clindamycin 21 (10.8) 0 (0.0) 1.000 NC
Pristinamycin 13 (6.7) 0 (0.0) 1.000 NC
Rifampin 89 (45.6) 2 (22.2) 0.966 2.94 (0.60–14.5)
Fusidic acid 8 (4.1) 3 (33.3) 0.049 0.09 (0.02–0.41)
Fluoroquinolones 10 (5.1) 0 (0.0) 1.000 NC
aThe differences between the groups were tested for statistical significance using a two-tailed Fisher’s exact test. P values were corrected for multiple testing using the
Holm-Bonferroni method.
bNC, not calculable.
doi:10.1371/journal.pone.0031548.t003
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31548Figure 2. Staphylococcus capitis isolates from distant neonatal intensive care units (NICUs) are clonal. Pulsed-field gel electrophoresis
(PFGE) was applied to 53 bloodstream isolates of S. capitis that were collected from NICU infants and adult patients from cities spanning the French
territory. The PFGE dendrogram was generated using the GelCompar software version 4.1. The isolates were assigned to pulsotypes using .80%
similarity (vertical dashed line). Staphylococcal chromosomal cassette mec (SCCmec) typing was applied to 23 methicillin-resistant isolates
representative of each pulsotype and geographic origin. All methicillin-resistant isolates from the different NICUs belonged to the same pulsotype
and shared a type V-related SCCmec element, whereas methicillin-susceptible and/or non-NICU isolates were genetically diverse. ccr, chromosomal
cassette recombinase; unkn., unknown (a combination of the mec complex and ccr genes has not been assigned to an SCCmec type so far).
doi:10.1371/journal.pone.0031548.g002
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have shown strains of this species to be clustered in a single
pulsotype [13,42]. It is unknown whether the spread of S. capitis
NRCS-A is limited to France or if these strains are present in the
NICUs of other countries. Molecular typing and a comparison of
the isolates from international sources are warranted to address
this question.
The reasons underlying the success of S. capitis pulsotype
NRCS-A in the NICU environment are not completely under-
stood. NICU isolates were found to be specifically resistant to the
antimicrobial agents used in these wards, namely beta-lactams,
aminosides and vancomycin [43], but not fluoroquinolones
(Table 2). This adapted resistance profile likely results from a
slow and progressive expansion of this clone in NICUs rather than
from a rapid epidemic spread. Heteroresistance to vancomycin has
been proposed as an intrinsic feature of the S. capitis species [23].
An increased tendency towards vancomycin resistance in pulso-
type NRCS-A isolates may have been a decisive feature that led to
their selection under high vancomycin pressure in the NICUs.
Whether S. capitis LOS in NICU infants is associated with
higher morbidity or treatment failure compared to other CoNS
pathogens is unknown. The present study was specifically designed
to address the prevalence and molecular characteristics of S. capitis
in the NICUs; therefore, we did not investigate the clinical course
of S. capitis bacteremia. Our findings suggest the need for a
prospective cohort study to determine whether specific risk factors
are associated with LOS due to S. capitis and to what extent
elevated vancomycin MICs in this pathogen correlate with an
impaired response to glycopeptide therapy.
Our study has limitations in addition to those inherent to its
retrospective design that need to be addressed. First, we used
laboratory-based definitions of CoNS bacteremia in NICU infants,
which determined that one CoNS-positive blood culture was
considered to be bacteremic in this population. It is likely that a
non-negligible proportion of CoNS-positive blood cultures includ-
ed in the analysis were false-positive, thus introducing a bias
towards an overestimation of CoNS prevalence as a cause of
bacteremia. Nonetheless, it is unlikely that the large difference in S.
capitis prevalence between NICU and adult ICU patients can be
explained by this inclusion bias. Second, although we have shown
that the S. capitis pulsotype NRCS-A is present in the NICUs of
several French cities, our prevalence study was limited to the
NICUs of a single town; therefore, it does not necessarily reflect
the regional epidemiology of S. capitis. Third, the over-represen-
tation of isolates from Lyon in our collection introduces a potential
underestimation of genetic diversity. However, because all of the
NICU isolates collected outside of Lyon belonged to pulsotype
NRCS-A, we can reasonably conclude that this sampling bias does
not account for the observed clonality of S. capitis in the NICUs.
Finally, one cannot exclude the possibility that this clonality
resulted from a lack of discriminatory power of SmaI PFGE
regarding the S. capitis species, but the high diversity of the PFGE
banding patterns in the isolates from adult patients does not
support this hypothesis. Furthermore, additional typing of a subset
of NRCS-A isolates from different cities using repetitive sequence-
based PCR [44] yielded indistinguishable banding patterns (data
not shown) that confirmed the close genetic relationship between
these isolates.
To conclude, the S. capitis pulsotype NRCS-A has adapted
remarkably to the NICU setting; it has overtaken S. epidermidis as
the leading pathogen that causes LOS in the NICUs of Lyon while
remaining virtually absent from adult patients. Microbiologists and
physicians in NICUs with high S. capitis prevalence should be
aware of the potential reduced vancomycin susceptibility of this
pathogen.
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